Delivery of therapeutic proteins through Lactococcus lactis

Biotechnol Genet Eng Rev. 2006:22:253-66. doi: 10.1080/02648725.2006.10648073.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antibodies / genetics
  • Antibodies / immunology
  • Antibodies / therapeutic use
  • Biological Products / genetics
  • Biological Products / pharmacology
  • Biological Products / therapeutic use
  • Colitis / microbiology
  • Colitis / therapy
  • Drug Delivery Systems
  • Humans
  • Hypersensitivity / microbiology
  • Hypersensitivity / therapy
  • Immunization
  • Inflammatory Bowel Diseases / microbiology
  • Inflammatory Bowel Diseases / therapy
  • Interleukin-10 / genetics
  • Interleukin-10 / metabolism
  • Interleukin-10 / therapeutic use
  • Intestinal Mucosa / microbiology*
  • Lactococcus lactis* / genetics
  • Lactococcus lactis* / metabolism
  • Mice
  • Organisms, Genetically Modified / genetics
  • Organisms, Genetically Modified / metabolism
  • Peptides / genetics
  • Peptides / therapeutic use
  • Protein Engineering
  • Trefoil Factor-1

Substances

  • Antibodies
  • Biological Products
  • Peptides
  • Tff1 protein, mouse
  • Trefoil Factor-1
  • Interleukin-10